Cargando…
Therapy of PsO in Special Subsets of Patients
Psoriasis is a chronic, inflammatory skin disease that may occur at any age, with a bimodal peak of incidence around the age of 16–20 years of age (early onset) and 57–60 years (late-onset). It is estimated that roughly 70% of patients develop the disease before the age of 40, which coincides with t...
Autores principales: | Di Cesare, Antonella, Ricceri, Federica, Rosi, Elia, Fastame, Maria Thais, Prignano, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687729/ https://www.ncbi.nlm.nih.gov/pubmed/36359399 http://dx.doi.org/10.3390/biomedicines10112879 |
Ejemplares similares
-
Insights into the Pathogenesis of HS and Therapeutical Approaches
por: Rosi, Elia, et al.
Publicado: (2021) -
Hidradenitis Suppurativa: The Influence of Gender, the Importance of Trigger Factors and the Implications for Patient Habits
por: Rosi, Elia, et al.
Publicado: (2022) -
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic
por: Rosi, Elia, et al.
Publicado: (2021) -
Clinical and Ultrasonographic Characterization of Hidradenitis Suppurativa in Female Patients: Impact of Early Recognition of the Disease
por: Di Cesare, Antonella, et al.
Publicado: (2023) -
Comment on “Oral lichenoid reaction in a psoriatic patient treated with secukinumab: A drug-related rather than a class-related adverse event?”
por: Di Cesare, Antonella, et al.
Publicado: (2019)